Your browser doesn't support javascript.
loading
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment.
van Doorn, Cassandra L R; Eckold, Clare; Ronacher, Katharina; Ruslami, Rovina; van Veen, Suzanne; Lee, Ji-Sook; Kumar, Vinod; Kerry-Barnard, Sarah; Malherbe, Stephanus T; Kleynhans, Léanie; Stanley, Kim; Hill, Philip C; Joosten, Simone A; van Crevel, Reinout; Wijmenga, Cisca; Critchley, Julia A; Walzl, Gerhard; Alisjahbana, Bachti; Haks, Mariëlle C; Dockrell, Hazel M; Ottenhoff, Tom H M; Vianello, Eleonora; Cliff, Jacqueline M.
Afiliação
  • van Doorn CLR; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Eckold C; Dept of Infection Biology and TB Centre, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom.
  • Ronacher K; SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa; Mater Research Institute -
  • Ruslami R; TB-HIV Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Hasan Sadikin General Hospital, Bandung, Indonesia.
  • van Veen S; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Lee JS; Dept of Infection Biology and TB Centre, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom.
  • Kumar V; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kerry-Barnard S; Population Health Research Institute, St George's Hospital Medical School, University of London.
  • Malherbe ST; SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
  • Kleynhans L; SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
  • Stanley K; SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
  • Hill PC; Centre for International Health, Division of Health Sciences, University of Otago, Dunedin, New Zealand.
  • Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • van Crevel R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Wijmenga C; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, the Netherlands.
  • Critchley JA; Population Health Research Institute, St George's Hospital Medical School, University of London.
  • Walzl G; SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
  • Alisjahbana B; TB-HIV Research Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Haks MC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Dockrell HM; Dept of Infection Biology and TB Centre, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom.
  • Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Vianello E; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: e.vianello@lumc.nl.
  • Cliff JM; Dept of Infection Biology and TB Centre, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom; Department of Life Sciences, Brunel University London, United Kingdom.
EBioMedicine ; 82: 104173, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35841871

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_cobertura_universal / 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis / 4_tuberculosis / 6_diabetes / 6_endocrine_disorders Assunto principal: Tuberculose / Diabetes Mellitus Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_cobertura_universal / 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis / 4_tuberculosis / 6_diabetes / 6_endocrine_disorders Assunto principal: Tuberculose / Diabetes Mellitus Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
...